Clinical Trial Update: A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic and clotting activity study of FVIII-PEGLip for Hemophilia A with inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• FVIII-PEGLip

Snippet

Sponsor: Ascension Healthcare Development Limited | Conditions: Hemophilia A With Inhibitor | Phase 2 | Status: UNKNOWN